一个AI-first框架用于阿尔茨海默病和相关痴呆症的多式联络数据
Varuna H Jasodanand1, Matteo Bellitti1, Vijaya B Kolachalama1,2
1Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 22, 2025
概括
整合阿尔茨海默病和相关痴呆症 (ADRD) 的各种数据至关重要. 一个AI-first策略可以统一数据结构和分析,以便更好地诊断和护理.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 生物医学数据科学 生物医学数据科学
背景情况:
- 了解和管理阿尔茨海默病和相关痴呆症 (ADRD) 需要整合各种数据模式.
- 像神经成像等传统诊断方法面临着可访问性限制,而像可穿戴设备和语音分析等新兴方法则面临着标准化和隐私方面的挑战.
- 不同质的数据流使不同的人口和环境中的多式联运集成变得复杂.
研究的目的:
- 为ADRD研究中多式联网数据集成提出"AI-first"战略.
- 在优化AI开发的统一原则中调整数据结构,协调和建模.
- 确保支持古典分析方法与现代人工智能的灵活性.
主要方法:
- 该展望概述了一个"AI-first"战略,用于结构化,协调和建模多式联网数据.
- 它强调了优化AI开发复杂,异构数据集的指导原则.
- 该战略旨在适应先进的人工智能和传统分析方法.
主要成果:
- 目前的分析方法和数据平台往往不足以适应ADRD中的现代基于AI的多式联络融合.
- 现代人工智能可以从混乱,多式联运和不完整的数据中学习,但需要专门构建的基础设施.
- 拟议的战略为早期诊断和ADRD的纵向护理提供了可扩展的工具.
结论:
- 重新思考ADRD数据系统以优先考虑AI兼容性至关重要.
- 一个"AI-first"的方法可以克服当前多式联运数据集成的局限性.
- 该战略支持开发可扩展的工具,以改善ADRD诊断和患者管理.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825


